Molecular Imaging Advances in Endometriosis: The Promise of Radiopharmaceuticals
Rebecca Napolitano, Giorgia Speltri, Petra Martini, Francesca Porto, Lorenza Marvelli, Alessandro Niorettini, Licia Uccelli, Luca Urso, Luca Filippi, Hatice Uslu, Burak Canitez, Hamza Alperen Kösem, Alessandra Boschi · 2025
Read Molecular Imaging Advances in Endometriosis: The Promise of Radiopharmaceuticals by Rebecca Napolitano, Giorgia Speltri, Petra Martini, Francesca Porto, Lorenza Marvelli, Alessandro Niorettini, Licia Uccelli, Luca Urso, Luca Filippi, Hatice Uslu, Burak Canitez, Hamza Alperen Kösem, Alessandra Boschi (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12786799.txt.
Description
Rebecca Napolitano and co-authors review tracer scans that might light up endometriosis, a painful womb-tissue disorder. The disease grows womb-like tissue outside the womb and scars it with fibrosis. Ultrasound and MRI show shape, not chemistry, and the standard PET tracer reads weakly here. Their 2025 review weighs receptor tracers that home in on active scar tissue instead.
The lead hope targets a protein switched on in busy fibroblasts, the cells that lay down scar. In diseased tissue that protein tracks with collagen load and immune cell counts. Older tracers suffer from glow in nearby organs or hit-and-miss reads. The team casts the fibroblast tracers as the most promising route to a clear, no-cut scan.
Catalog record
| CREATOR | Rebecca Napolitano, Giorgia Speltri, Petra Martini, Francesca Porto, Lorenza Marvelli, Alessandro Niorettini, Licia Uccelli, Luca Urso, Luca Filippi, Hatice Uslu, Burak Canitez, Hamza Alperen Kösem, Alessandra Boschi |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |